Align Partners Capital Management Inc. (“Align Partners”), a shareholder of Dentium Co., Ltd. (“Dentium” or the “Company”), has submitted formal shareholder proposals for inclusion in the agenda of Dentium’s upcoming 26th Annual General Meeting (“AGM”), urging the Company to strengthen governance practices and improve capital allocation discipline.
Align Partners noted that, given that shareholder proposals will be presented at this year’s AGM, Dentium should follow the Korea Exchange (KRX) Corporate Governance Key Indicators by publishing the AGM convocation notice at least four weeks prior to the meeting date and adopting an electronic voting system to enhance shareholder participation.
Dentium is widely recognized as a global leader in the dental implant industry, supported by superior technology and more than 23 years of long-term clinical data. Despite this strong positioning, Align Partners believes the Company continues to trade at a meaningful discount. As of February 11, 2026, Dentium traded at an LTM EV/EBITDA multiple of 6.6x and a PBR of 0.77x, compared to global peer averages of 14.0x and 3.13x, respectively. Align Partners views this valuation gap as structural rather than purely cyclical.
Align Partners believes market confidence has been weakened by governance concerns, including related-party transactions involving affiliates linked to the controlling shareholder and limited independent Board oversight. In addition, Align Partners raised concerns regarding insufficient disclosure around investments in a hydrogen fuel cell business, where synergies with the Company’s core implant operations remain unclear.
Since its initial investment, Align Partners has engaged with Dentium through private letters and meetings with management and the Board. While certain measures have been acknowledged, Align Partners concluded that progress on fundamental governance and capital allocation issues remains insufficient. Accordingly, Align Partners has decided to proceed with formal shareholder proposals for the AGM.
Align Partners submitted the following proposals for shareholder vote:
Align Partners stated that these proposals are intended to strengthen Board independence, improve transparency, and restore investor confidence in Dentium’s long-term strategic direction.
About Align Partners Capital Management Inc.
Align Partners Capital Management Inc. is an investment company focused on Korea. Led by CEO Changhwan Lee, Align Partners leverages its expertise in private equity and investment banking to engage with portfolio companies to address governance inefficiencies and the “Korea discount.”
Source: https://www.alignpartnerscap.com
News 07 April 2026
Angelalign Technology Inc. (6699.HK) (“Angel” or the “company”) released its financial results for fiscal year 2025. During the reporting period, the company continued to do well in both the...
In an effort designed to educate and assist dental support organizations (DSOs) in meeting the growing demand for delivering clear aligner therapies, Clear Aligner Advisor recently announced a...
The digital dentistry revolution is transforming not just workflows but global access to care. With this in mind—and with today being World Oral Health Day—Align Technology is highlighting the...
Clarity Aligners from Solventum are nearly invisible and extruded in 2 thicknesses to express different mechanical force levels.
News 27 February 2026
Angelalign Technology Inc. (6699.HK) (“Angel”) said a ruling by the Unified Patent Court of Düsseldorf, Germany, that it preliminarily cease its use of certain software functions that...
Prosthodontics 16 April 2026
The use of orthodontics before fixed prosthodontics in restorative dentistry
For a variety of reasons, orthodontic intervention is often overlooked as a viable modality to correct occlusal, axial, rotational, and space discrepancies before undertaking fixed prosthetic...
Editorials 16 April 2026
Congratulations to Ane Poly, D.D.S., M.Sc., Ph.D., a clinical assistant professor in the UF Department of Endodontics, who was recently chosen as the college’s representative to the Council of...
ONEDAYBIOTECH products garner honor as one of the 16th Annual Readers’ Choice Top 25 Implant Products
News 16 April 2026
National leader in oral health integration and equity joins CareQuest Institute executive team.
News 16 April 2026
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...